Moxi Tech 400mg./ 250 ml.

Pharmaceutical form

Solution for infusion
Clear, yellow solution.

Therapeutic indications:

Moxitech is indicated for the treatment of:

  • Community-acquired pneumonia
  • Complicated skin and skin structure infections

Moxifloxacin should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Mechanism of Action:

Inhibits A subunits of DNA gyrase, resulting in inhibition of bacterial DNA replication and transcription


The recommended dose is 400 mg moxifloxacin, infused once daily.


Hypersensitivity to moxifloxacin or any member of the quinolone class of antibacterials


PharmaTech CJSC